Shareholders approve all agenda items at Cosmo shareholders meeting
Amsterdam - May 25, 2017 - Cosmo Pharmaceuticals S.p.A. (SIX: COPN) today announced that the shareholders approved all agenda items at the shareholders meeting in Amsterdam on May 24, 2014 with overwhelming majorities.
7'629'838 votes representing 50.74% of the total votes were present.
The accounts were approved with a majority of 99.4% of the votes and the board was discharged with 99.3% of the votes.
Ms Eimar Cowhey was elected to the board of directors as a non-executive with 96.8% of the votes.
The remuneration policy was approved with 93.8% of the votes, 96.1% of the votes granted the authority to the board to create preferred shares, 99.8% approval was given to the authority to repurchase up to 10% of the shares and 96.1% of the votes were given to the new employee stock ownership plan.
The payment of a gross dividend of EUR 1.50 per share was approved with 100% of the votes. The ex dividend date is May 29, 2017, the dividend record date is May 30, 2017 and the dividend payment date is May 31, 2017.
Provider | Channel | Contact | ||
---|---|---|---|---|
Tensid EQS Ltd., Switzerland www.tensid.ch |
newsbox.ch www.newsbox.ch |
Provider/Channel related enquiries marco@tensid.ch +41 41 763 00 50 |